Related Experiment Video

Updated: Jul 9, 2026

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
08:38

Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia

Published on: August 28, 2013

Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling

William A Ricke1, Stephen J McPherson, Joseph J Bianco

  • 1Department of Urology, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA. william_ricke@urmc.rochester.edu

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|December 7, 2007
PubMed

Insights

Antiestrogens show promise in preventing prostate cancer (PRCA). Estrogen receptor alpha (ER alpha) signaling is crucial for PRCA development, suggesting ER alpha antagonism as a therapeutic strategy.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Antiestrogens have shown potential in preventing prostate cancer (PRCA).
  • The specific source of estradiol (E2) contributing to PRCA and the involved estrogen receptor (ER) pathway remain unclear.
  • Understanding these factors is crucial for developing effective PRCA prevention strategies.

Purpose of the Study:

  • To investigate the role of endogenous estradiol (E2) production in PRCA development.
  • To determine the specific estrogen receptor (ER) pathway, ER alpha or ER beta, mediating PRCA.
  • To establish a novel mouse model for studying PRCA and evaluating therapeutic interventions.

Main Methods:

  • Developed a novel mouse model of PRCA using testosterone and E2 stimulation.
  • Utilized aromatase-knockout (ArKO) mice to assess the impact of in situ E2 production.
  • Employed ER alpha-knockout (alphaERKO) and ER beta-knockout (betaERKO) mice to differentiate ER pathway roles.

Main Results:

  • ArKO mice exhibited reduced PRCA incidence compared to wild-type mice, implicating local E2 production.
  • Prostates from alphaERKO mice remained free of pathology, while betaERKO mice showed similar carcinogenesis to wild-type.
  • These findings strongly suggest ER alpha is the key mediator of E2-driven PRCA.

Conclusions:

  • In situ E2 production significantly influences PRCA development.
  • Estrogen receptor alpha (ER alpha) signaling is essential for prostate carcinogenesis.
  • Targeting ER alpha, but not ER beta, may be an effective strategy for PRCA prevention and treatment.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Secondary Messengers in Hormone Action01:26

Secondary Messengers in Hormone Action

Water-soluble hormones cannot cross the plasma membrane, so they rely on protein receptors that span the membrane to trigger intracellular signaling pathways. These pathways then activate second messengers inside the cell, including cAMP or calcium ions.
Many hormones bind to transmembrane G protein-coupled receptors that connect to regulatory G proteins. These G proteins can then activate enzymes such as adenylyl cyclase or phospholipase C. Adenylyl cyclase converts ATP to cAMP, activating...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.